Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healthcare Global Enterprises (HCG) is India's largest provider of cancer care, operating a comprehensive network of oncology centers, multispecialty hospitals, and fertility clinics. Headquartered in Bengaluru, the company offers advanced diagnostic and therapeutic services, including radiation oncology, surgical oncology, medical oncology, and genomic testing. HCG also operates fertility centers under the 'Milann' brand and diagnostic labs under 'Triesta Sciences'. In early 2025, global investment firm KKR acquired a controlling stake in HCG from CVC Capital Partners to support its expansion and infrastructure development. The company is known for pioneering advanced cancer care technologies in India, such as CyberKnife and AI-driven radiation therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Care Global.